Glutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: Implications for Parkinson's disease

Antioxidants and Redox Signaling

Volumn 7, Issue 7-8, 2005, Pages 900-910

  Bharath, Srinivas ^a   Andersen, Julie Kay ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; CYSTEINE; GLUTATHIONE; PEROXYNITRITE; POLYPEPTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TYROSINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CELL IMMORTALIZATION; CELL VIABILITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; MESENCEPHALON; MOUSE; NITRATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; SILVER STAINING; SUCROSE GRADIENT;

ANIMALS; BRAIN; CELL LINE; CELL SURVIVAL; DOPAMINE; ELECTRON TRANSPORT COMPLEX I; GLUTATHIONE; MESENCEPHALON; MICE; MITOCHONDRIA; NITRATES; PARKINSON DISEASE; PEROXYNITROUS ACID; PROTEIN SUBUNITS; RATS; TYROSINE;

EID: 22044436635     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.900     Document Type: Article

References (36)

1. Adams FS, La Rosa FG, Kumar S, Edwards-Prasad J, Kentroti S, Vernadakis A, Freed CR, and Prasad KN. Characterization and transplantation of two neuronal cell lines with dopaminergic properties. Neurochem Res 21: 619-627, 1996.
2. Andersen JK. Do alterations in glutathione and iron levels contribute to pathology associated with Parkinson's disease? Novartis Found Symp 235: 11-20, 2001.
3. Balijepalli S, Annepu J, Boyd MR, and Ravindranath V. Effect of thiol modification on brain mitochondrial complex 1 activity. Neurosci Lett 272: 203-206, 1999.
4. Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 31: 119-130, 1992.
5. Beal MF. Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci 23: 298-304, 2000.
6. Bharat S, Cochran BC, Hsu M, Liu J, Ames BN, and Andersen JK. Pre-treatment with R-lipoic acid alleviates the effects of GSH depletion in PC 12 cells: implications for Parkinson's disease therapy. Neurotoxicology 23: 479-486, 2002.
7. Byun J, Henderson JP, Mueller DM, and Heinecke JW. 8-Nitro-2′- deoxyguanosine, a specific marker of oxidation by reactive nitrogen species, is generated by the myeloperoxidase-hydrogen peroxide-nitrite system of activated human phagocytes. Biochemistry 38: 2590-2600, 1999.
8. Clarkson ED, Rosa FG, Edwards-Prasad J, Weiland DA, Witta SE, Freed CR, and Prasad KN. Improvement of neurological deficits in 6-hydroxydopamine- lesioned rats after transplantation with allogeneic simian virus 40 large tumor antigen gene-induced immortalized dopamine cells. Proc Natl Acad Sci U S A 95: 1265-1270, 1998.
9. Clarkson ED, Zawada WM, Adams FS, Bell KP, and Freed CR. Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats. Brain Res 806: 60-68, 1998.
10. Clementi E, Brown GC, Feelisch M, and Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role ofS-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci U S A 95: 7631-7636, 1998.
11. Dawson TM and Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822, 2003.
12. Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Eees A, Jenner P, and Marsden CD. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52: 381-389, 1989.
13. Forno LS. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55: 259-272, 1996.
14. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, and Lee VM. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290: 985-989, 2000.
15. Hanson BJ, Schulenberg B, Patton WF, and Capaldi RA. A novel subfractionation approach for mitochondrial proteins: a three-dimensional mitochondrial proteome map. Electrophoresis 22: 950-959, 2001.
16. Jain A, Martensson J, Stole E, Auld PA, and Meister A. Glutathione deficiency leads to mitochondrial damage in brain. Proc Natl Acad Sci U S A 88: 1913-1917, 1991.
17. Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol 53 Suppl 3: 826-836, 2003.
18. Jha N, Jurma O, Lalli G, Liu Y, Pettus EH, Greenamyre JT, Liu RM, Forman HJ, and Andersen JK. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. J Biol Chem 275: 26096-26101, 2000.
19. Lenaz G, Bovina C, Castelluccio C, Fato R, Formiggini G, Genova ML, Marchetti M, Pich MM, Pallotti F, Parenti Castelli G, and Biagini G. Mitochondrial complex I defects in aging. Mol Cell Biochem 178: 329-333, 1997.
20. Lin TK, Hughes G, Muratovska A, Blaikie FH, Brookes PS, Darley-Usmar V, Smith RA, and Murphy MP. Specific modification of mitochondrial protein thiols in response to oxidative stress: a proteomics approach. J Biol Chem 277: 17048-17056, 2002.
21. Murray J, Taylor SW, Zhang B, Ghosh SS, and Capaldi RA. Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry. J Biol Chem 278: 37223-37230, 2003.
22. Pennathur S. Jackson-Lewis V, Przedborski S, and Heinecke JW. Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease. J Biol Chem 274: 34621-34628, 1999.
23. Perry TL and Yong VW. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett 67: 269-274, 1986.
24. Prasad KN, Carvalho E, Kentroti S, Edwards-Prasad J, Freed C, and Vernadakis A. Establishment and characterization of immortalized clonal cell lines from fetal rat mesencephalic tissue. In Vitro Cell Dev Biol Anim 30A: 596-603, 1994.
25. Radi R, Beckman JS, Bush KM, and Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288: 481-487, 1991.
26. Schagger H and Pfeiffer K. Supercomplexes in the respiratory chains of yeast and mammalian mitochondria. EMBO J 19: 1777-1783, 2000.
27. Schagger H and von Jagow G. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 199: 223-231, 1991.
28. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, and Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54: 823-827, 1990.
29. Sies H, Sharov VS, Klotz LO, and Briviba K. Glutathione peroxidase protects against peroxynitrite-mediated oxidations. A new function for selenoproteins as peroxynitrite reductase. J Biol Chem 272: 27812-27817, 1997.
30. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, and Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17: 2653-2657, 1997.
31. Sriram K, Shankar SK, Boyd MR, and Ravindranath V. Thiol oxidation and loss of mitochondrial complex I precede excitatory amino acid mediated neurodegeneration. J Neurosci 18: 10287-10296, 1998.
32. Taylor ER, Hurrell F, Shannon RJ, Lin TK, Hirst J, and Murphy MP. Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J Biol Chem 278: 19603-19610, 2003.
33. Taylor SW, Warnock DE, Glenn GM, Zhang B, Fahy E, Gaucher SP, Capaldi RA, Gibson BW, and Ghosh SS. An alternative strategy to determine the mitochondrial proteome using sucrose gradient fractionation and ID PAGE on highly purified human heart mitochondria. J Proteome Res 1: 451-458, 2002.
34. Taylor SW, Fahy E, Murray J, Capaldi RA, and Ghosh SS. Oxidative post-translational modification of tryptophan residues in cardiac mitochondrial proteins. J Biol Chem 278: 19587-19590, 2003.
35. Trounce IA, Kim YL, Jun AS, and Wallace DC. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 264: 484-509, 1996.
36. Zhang Y, Dawson VL, and Dawson TM. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol Dis 7: 240-250, 2000.